Company / Operating Income
Day One Biopharmaceuticals, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$127.8M
FY2025
5-year range
-$217.3M / -$72.7M
FY2021-FY2025
Trend
+41.2%
vs FY2024
Sector context
#103 of 202
Health Care
What the data says
At -$128M, Day One Biopharmaceuticals, Inc.'s operating income ranks #103 of 202 in the Health Care sector. Operating Income returned to growth in FY2025 after 4 years of decline, reaching -$128M.
Based on SEC 10-K filings.
-$128M in FY2025.
Improved from -$206M to -$128M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 202 in Health CareTop 51% of 202This company -$127.8M Sector average $86.7M
▼
-247.4% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 41.2% year-over-year.
- Ranks #103 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2024.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$127.8M | +41.2% |
| FY2024 | -$217.3M | -5.4% |
| FY2023 | -$206.1M | -40.3% |
| FY2022 | -$146.9M | -102.0% |
| FY2021 | -$72.7M | -427.8% |
| FY2020 | -$13.8M | +7.5% |
| FY2019 | -$14.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026